Article Details
Retrieved on: 2024-03-06 23:29:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
With its third fund, the firm is targeting areas like AI, synthetic biology, and cell and gene therapy. Published March 6, 2024.
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here